CHARACTERIZATION OF A REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY TYPE 2 PROVIRAL CLONE
Japan
1990-505498
Filed on 1990-03-22
1990-505498
Filed on 1990-03-22
CHARACTERIZATION OF A REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY TYPE 2 PROVIRAL CLONE
Israel
93927
Filed on 1990-03-22
93927
Filed on 1990-03-22
CHARACTERIZATION OF A REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY TYPE 2 PROVIRAL CLONE
Canada
2047181
Filed on 1990-03-22
2047181
Filed on 1990-03-22
CHARACTERIZATION OF A REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY TYPE 2 PROVIRAL CLONE
Australia
53536/90
Filed on 1990-03-22
53536/90
Filed on 1990-03-22
Metalloproteinase Inhibitor Peptides (TIMP-2)
Belgium
90905905.7
Filed on 1990-03-21
90905905.7
Filed on 1990-03-21
MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
Luxembourg
90904575.9
Filed on 1990-03-01
90904575.9
Filed on 1990-03-01
MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
Japan
2000-132398
Filed on 1990-03-01
2000-132398
Filed on 1990-03-01
MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
Denmark
90904575.9
Filed on 1990-03-01
90904575.9
Filed on 1990-03-01
MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
Belgium
90904575.9
Filed on 1990-03-01
90904575.9
Filed on 1990-03-01